Evidence map›Paper›PMID 24173696›Full record

ArticleClinical & experimental metastasis2014

Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.

Leandro Marcelo Martinez, Valeria Beatriz Fernández Vallone, Vivian Labovsky, Hosoon Choi, Erica Leonor Hofer, Leonardo Feldman, Raúl Horacio Bordenave, Emilio Batagelj, Federico Dimase, Ana Rodriguez Villafañe and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Connecting the dots: (RANKLTranslational lung cancer research · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Hallmarks of Bone Metastasis.Calcified tissue international · 2018
    Review
  14. Article
  15. Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Leandro Marcelo MartinezImmunohematology Laboratory, Experimental Biology and Medicine Institute (IBYME), National Council of Scientific and Technical Research (CONICET), 2490 Vuelta de Obligado, 1428, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
Valeria Beatriz Fernández Vallone
Vivian Labovsky
Hosoon Choi
Erica Leonor Hofer
Leonardo Feldman
Raúl Horacio Bordenave
Emilio Batagelj
Federico Dimase
Ana Rodriguez Villafañe
Norma Alejandra Chasseing
Consejo Nacional de Investigaciones Científicas y Técnicas · ARFavaloro Foundation · ARTexas A&M Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastasis is an incurable complication of breast cancer affecting 70-80 % of advanced patients. It is a multistep process that includes tumour cell mobilisation, intravasation, survival in the circulation, extravasation, migration and proliferation in the bone marrow/bone. Although novel findings demonstrate the bone marrow microenvironment significance in bone metastatic progression, a majority of studies have focused on end-stage disease and little is known about how the pre-metastatic niche arises in the bone marrow/bone tissues. We demonstrated a significant increase in patients' peripheral blood plasma ability to induce transendothelial migration of MCF-7 cells compared with healthy volunteers. Moreover, high RANKL, MIF and OPG levels in patients' peripheral blood could play a role in the intravasation, angiogenesis, survival and epithelial-mesenchymal transition of circulating tumour cells. Also, we observed a significant increase in patients' bone marrow plasma capacity to induce transendothelial migration of MDA-MB231 and MCF-7 cells compared with healthy volunteers. Furthermore, patients' bone marrow mesenchymal stem cells could control the recruitment of tumour cells, modifying the MCF-7 and MDA-MB231 cell migration. In addition, we found a significantly higher MDA-MB231 cell proliferation when we used patients' bone marrow plasma compared with healthy volunteers. Interestingly, PDGF-AB, ICAM-1 and VCAM-1 levels in patients' bone marrow were significantly higher than the values of healthy volunteers, suggesting that they could be involved in the cancer cell extravasation, bone resorption and cancer cell proliferation. We believe that these results can reveal new information about what alterations happen in the bone marrow of advanced breast cancer patients before bone colonisation, changes that create optimal soil for the metastatic cascade progression.

Indexed as

ApoptosisBone MarrowBone NeoplasmsBreast NeoplasmsCell Line, TumorCell ProliferationEnzyme-Linked Immunosorbent AssayFemaleHumansImmunohistochemistryNeoplasm Metastasis

Identifiers

PMID24173696
OpenAlexW2015716451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.